Moreover, isoliquiritigenin, a flavonoid compound, has been shown to improve motor deficits in a PD mice model through the upregulation of Nrf2 and NQO1, while concurrently downregulating proinflammatory mediators [154]. This evidence concerns the gene NFE2L2 and Parkinson disease.